1. |
Tricarico D, Camerino DC. Recent advances in the pathogenesis and drug action in periodic paralyses and related channelopathies[J]. Front Pharmacol, 2011, 2(8):8.
|
2. |
Thompson MP, Pinckard JK. A rare case of thyrotoxic periodic paralysis presenting to the medical examiner[J]. Am J Forensic Med Pathol, 2011, 32(3):232-235.
|
3. |
Abbasi B, Sharif Z, Sprabery LR. Hypokalemic thyrotoxic periodic paralysis with thyrotoxic psychosis and hypercapnic respiratory failure[J]. Am J Med Sci, 2010, 340(2):147-153.
|
4. |
Wang W, Jiang L, Ye L, et al. Mutation screening in Chinese hypokalemic periodic paralysis patients[J]. Mol Genet Metab, 2006, 87(4):359-363.
|
5. |
Maciel RM, Lindsey SC, Dias da Silva MR. Novel etiopathophysiological aspects of thyrotoxic periodic paralysis[J]. Nat Rev Endocrinol, 2011, 7(11):657-667.
|
6. |
Jurkat-Rott K, Weber MA, Fauler M, et al. K+-dependent paradoxical membrane depolarization and Na+ overload, major and reversible contributors to weakness by ion Channel leaks[J]. Proc Natl Acad Sci USA, 2009, 106(10):4036-4041.
|
7. |
Matthews E, Labrum R, Sweeney MG, et al. Voltage sensor charge loss accounts for most cases of hypokalemic periodic paralysis[J]. Neurology, 2009, 72(18):1544-1547.
|
8. |
Wang Q, Liu M, Xu C, et al. Novel CACNA1S mutation causes autosomal dominant hypokalemic periodic paralysis in a Chinese family[J]. J Mol Med, 2005, 83(3):203-208.
|
9. |
Arhem P. Voltage sensing in ion channels:a 50-year-old mystery resolved?[J]. Lancet, 2004, 363(9416):1221-1223.
|
10. |
Chabrier S, Monnier N, Lunardi J. Early onset of hypokalaemic periodic paralysis caused by a novel mutation of the CACNA1S gene[J]. J Med Genet, 2008, 45(10):686-688.
|
11. |
翟金盛, 李卫巍, 安丽梅, 等. 低钾周期性麻痹家系CACNA1S基因突变的研究[J]. 医学研究生学报, 2012, 25(5):489-492.
|
12. |
Li FF, Li QQ, Tan ZX, et al. A novel mutation in CACNA1S gene associated with hypokalemic periodic paralysis which has a gender difference in the penetrance[J]. J Mol Neurosci, 2012, 46(2):378-383.
|
13. |
Sung CC, Cheng CJ, Lo YF, et al. Genotype and phenotype analysis of patients with sporadic periodic paralysis[J]. Am J Med Sci, 2012, 343(4):281-285.
|
14. |
Matthews E, Hanna MG. Muscle channelopathies:does the predicted Channel gating pore offer new treatment insights for hypokalaemic periodic paralysis?[J]. J Physiol, 2010, 588(Pt 11):1879-1886.
|
15. |
Park YH, Kim JB. An atypical phenotype of hypokalemic periodic paralysis caused by a mutation in the Sodium Channel gene SCN4A[J]. Korean J Pediatr, 2010, 53(10):909-912.
|
16. |
Hong D, Luan X, Chen B, et al. Both hypokalaemic and normokalaemic periodic paralysis in different members of a single family with novel R1129Q mutation in SCN4A gene[J]. J Neurol Neurosurg Psychiatry, 2010, 81(6):703-704.
|
17. |
Phakdeekitcharoen B, Phudhichareonrat S, Pookarnjanamorakot C, et al. Thyroid hormone increases mRNA and protein expression of Na+-K+-ATPase alpha2 and beta1 subunits in human skeletal muscles[J]. J Clin Endocrinol Metab, 2007, 92(1):353-358.
|
18. |
Li W, Changsheng C, Jiangfang F, et al. Effects of sex steroid hormones, thyroid hormone levels, and insulin regulation on thyrotoxic periodic paralysis in Chinese men[J]. Endocrine, 2010, 38(3):386-390.
|
19. |
Soonthornpun S, Setasuban W, Thamprasit A. Insulin resistance in subjects with a history of thyrotoxic periodic paralysis (TPP)[J]. Clin Endocrinol (Oxf), 2009, 70(5):794-797.
|
20. |
Kung AW. Thyrotoxic periodic paralysis:a diagnostic challenge[J]. J Clin Endocrinol Metab, 2006, 91(7):2490-2495.
|
21. |
Dias Da Silva MR, Cerutti JM, Arnaldi LA, et al. A mutation in the KCNE3 Potassium Channel gene is associated with susceptibility to thyrotoxic hypokalemic periodic paralysis[J]. J Clin Endocrinol Metab, 2002, 87(11):4881-4884.
|
22. |
Tang NL, Chow CC, Ko GT, et al. No mutation in the KCNE3 Potassium Channel gene in Chinese thyrotoxic hypokalaemic periodic paralysis patients[J]. Clin Endocrinol (Oxf), 2004, 61(1):109-112.
|
23. |
Kung AW, Lau KS, Fong GC, et al. Association of novel single nucleotide polymorphisms in the Calcium Channel alpha 1 subunit gene (Ca(v)1.1) and thyrotoxic periodic paralysis[J]. J Clin Endocrinol Metab, 2004, 89(3):1340-1345.
|
24. |
Ryan DP, da Silva MR, Soong TW, et al. Mutations in Potassium Channel Kir2.6 cause susceptibility to thyrotoxic hypokalemic periodic paralysis[J]. Cell, 2010, 140(1):88-98.
|
25. |
Cheng CJ, Lin SH, Lo YF, et al. Identification and functional characterization of Kir2.6 mutations associated with non-familial hypokalemic periodic paralysis[J]. J Biol Chem, 2011, 286(31):27425-27435.
|
26. |
Jongjaroenprasert W, Phusantisampan T, Mahasirimongkol S, et al. A genome-wide association study identifies novel susceptibility genetic variation for thyrotoxic hypokalemic periodic paralysis[J]. J Hum Genet, 2012, 57(5):301-304.
|
27. |
Cheung CL, Lau KS, Ho AY, et al. Genome-wide association study identifies a susceptibility locus for thyrotoxic periodic paralysis at 17q24.3[J]. Nat Genet, 2012, 44(9):1026-1029.
|